Sustained funding to ensure access to anti-vascular endothelial growth factor drugs

(July 2019)

Access Details

Read the full position paper from the Canadian Retina Society (CRS)

Necessity of Sustained Funding to Ensure Access to Anti-Vascular Endothelial Growth Factor Drugs Download

Related Resources

So You Got a Complaint – Now What?!

Articles Patients’ complaints involving ophthalmologists in the province of Ontario,...

More Info

Immediate Sequential Bilateral Cataract Surgery (ISBCS) COVID-19 Considerations

Updated March, 2021 This document, which is subject to regular...

More Info

COVID-19 Vaccination Tool Kit for Health Care Providers

The current edition of the tool kit includes information on...

More Info

Why Do My Eyes Burn When I Cry? Causes and Treatments healthline.com/health/eye-hea… via @Healthline

About 4 hours ago from Can Ophthal Society's Twitter via Twitter for Android

Keep an eye on it: Increased pandemic screen time impacting eye health of Atlantic Canadians | The Chronicle Herald thechronicleherald.ca/lifesty…

About 6 days ago from Can Ophthal Society's Twitter via Twitter for Android

Submissions for the Innovation in Retina Research Award being offered by COS with the support of Bayer Inc. are now being accepted. Residents or fellows enrolled in a Canadian clinical training program are encouraged to apply! cos2021.cos-sco.ca/sites/cos-…

Last week from Can Ophthal Society's Twitter via Twitter Web App

Egypt’s Nihal Shakankiry among 100 most influential women in ophthalmology globally. egyptindependent.com/egypts-n…

About a week ago from Can Ophthal Society's Twitter via Twitter for Android

Wine consumption may prevent cataracts, study finds ophthalmologytimes.com/view/w… via @OphthTimes

About 2 weeks ago from Can Ophthal Society's Twitter via Twitter for Android

Can Ophthal Society's Twitter via Twitter Web Client